Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial

Mwinga, A; Nunn, A; Ngwira, B; Chintu, C; Warndorff, D; Fine, P; Darbyshire, J; Zumla, A; (2002) Mycobacterium vaccae (SRL172) immunotherapy as an adjunct to standard antituberculosis treatment in HIV-infected adults with pulmonary tuberculosis: a randomised placebo-controlled trial. Lancet, 360 (9339). pp. 1050-5. ISSN 0140-6736 DOI: https://doi.org/10.1016/S0140-6736(02)11141-X

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1016/S0140-6736(02)11141-X

Abstract

Share

Download

Full text not available from this repository.

Downloads

View details

Metrics & Citations


Google Scholar